Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Divestments (2020)

Historic Divestments for Theravance Biopharma (TBPH) over the last 1 years, with Q1 2020 value amounting to $14.9 million.

  • Theravance Biopharma's Divestments changed N/A to $14.9 million in Q1 2020 from the same period last year, while for Dec 2022 it was $14.9 million, marking a year-over-year change of. This contributed to the annual value of $1.1 billion for FY2022, which is N/A changed from last year.
  • As of Q1 2020, Theravance Biopharma's Divestments stood at $14.9 million.
  • Theravance Biopharma's 5-year Divestments high stood at $14.9 million for Q1 2020, and its period low was $14.9 million during Q1 2020.